Literature DB >> 15640990

Plasma homocysteine level and functional outcome of patients with ischemic stroke.

Eliyahu H Mizrahi1, Yehudit Fleissig, Marina Arad, Abraham Adunsky.   

Abstract

OBJECTIVE: To investigate the possible relationships between total plasma homocysteine level (tHcy) and functional outcome of stroke patients as evaluated by the FIM instrument.
DESIGN: Retrospective chart analysis.
SETTING: Inpatient stroke rehabilitation ward of a university-affiliated referral hospital. PARTICIPANTS: Consecutive patients (N=113) presenting with acute ischemic stroke. Patients were divided into 2 groups according to their tHcy levels (< or = 15 micromol/L, >15 micromol/L) and into 3 groups according to their FIM scores (low, < or =40; moderate, 41-80; high, >80).
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: The tHcy level was determined shortly after stroke onset by a high performance liquid chromatography method with fluorescence detection. Functional outcome was measured by the FIM instrument at admission and discharge. The tHcy level and FIM scores were obtained for all patients. Data outcomes were analyzed by t tests, 1-way analysis of variance, Mann-Whitney U, and Fisher exact tests, as well as by the 2 ordered polytomous logistic regression model.
RESULTS: The 2 tHcy groups were similar in demographic, stroke, and comorbidity characteristics, differing only by higher frequency of hypertension in those with a tHcy greater than 15 micromol/L (51.7% vs 80.8%, respectively, P=.01). Compared with patients who had tHcy levels at 15 micromol/L or lower and were discharged from rehabilitation being in the highest FIM score group (>80), higher tHcy levels were not associated with a discharge FIM score of less than 40 (odds ratio [OR]=.77; 95% confidence interval [CI], 0.13-4.65; P=.77) or with a better functional outcome FIM score between 40 and 80 (OR=3.71; 95% CI, 0.73-18.99; P=.11).
CONCLUSIONS: Our findings suggest that determination of tHcy level does not correlate with functional outcome in patients presenting for rehabilitation after acute ischemic stroke.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15640990     DOI: 10.1016/j.apmr.2004.01.031

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  10 in total

1.  Plasma Homocysteine and Prognosis of Acute Ischemic Stroke: a Gender-Specific Analysis From CATIS Randomized Clinical Trial.

Authors:  Chongke Zhong; Tan Xu; Tian Xu; Yanbo Peng; Aili Wang; Jinchao Wang; Hao Peng; Qunwei Li; Deqin Geng; Dongsheng Zhang; Yuming Zhang; Yonghong Zhang; Xiang Gao; Jiang He
Journal:  Mol Neurobiol       Date:  2016-02-24       Impact factor: 5.590

2.  The Prognostic Value of Homocysteine in Acute Ischemic Stroke Patients: A Systematic Review and Meta-Analysis.

Authors:  Shengming Huang; Jirui Cai; Yuejun Tian
Journal:  Front Syst Neurosci       Date:  2021-02-12

3.  High homocysteine and blood pressure related to poor outcome of acute ischemia stroke in Chinese population.

Authors:  Chongke Zhong; Liying Lv; Changjiang Liu; Liang Zhao; Mo Zhou; Wenjie Sun; Tan Xu; Weijun Tong
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

4.  No Association between Elevated Total Homocysteine Levels and Functional Outcome in Elderly Patients with Acute Cerebral Infarction.

Authors:  Wanjun Wang; Chunlin Gao; Changshen Yu; Shoufeng Liu; Dongzhe Hou; Yajing Wang; Chen Wang; Lidong Mo; Jialing Wu
Journal:  Front Aging Neurosci       Date:  2017-03-21       Impact factor: 5.750

5.  The Impact of Homocysteine, Vitamin B12, and Vitamin D Levels on Functional Outcome after First-Ever Ischaemic Stroke.

Authors:  Merdin Markišić; Aleksandra M Pavlović; Dragan M Pavlović
Journal:  Biomed Res Int       Date:  2017-03-23       Impact factor: 3.411

6.  Impact of homocysteine levels on clinical outcome in patients with acute ischemic stroke receiving intravenous thrombolysis therapy.

Authors:  Lei Li; Xiaoye Ma; Li Zeng; Sajan Pandey; Ronghao Wan; Rui Shen; Quanbin Zhang
Journal:  PeerJ       Date:  2020-07-10       Impact factor: 2.984

7.  Clinical Utility of Serum Holotranscobalamin Measurements in Patients with First-Ever Ischemic Stroke.

Authors:  Oh Joo Kweon; Yong Kwan Lim; Mi-Kyung Lee; Hye Ryoun Kim
Journal:  Dis Markers       Date:  2021-09-10       Impact factor: 3.434

8.  Homocysteine is associated with higher risks of ischemic stroke: A systematic review and meta-analysis.

Authors:  Nícollas Nunes Rabelo; João Paulo Mota Telles; Leonardo Zumerkorn Pipek; Rafaela Farias Vidigal Nascimento; Rodrigo Coimbra de Gusmão; Manoel Jacobsen Teixeira; Eberval Gadelha Figueiredo
Journal:  PLoS One       Date:  2022-10-13       Impact factor: 3.752

9.  Functionality of patients with post-stroke hemiplegia: Does serum folate level matter?

Authors:  İlke Coşkun Benlidayı; Sibel Başaran
Journal:  Turk J Phys Med Rehabil       Date:  2019-05-03

10.  Exploratory study of plasma total homocysteine and its relationship to short-term outcome in acute ischaemic stroke in Nigerians.

Authors:  Njideka U Okubadejo; Olajumoke O Oladipo; Adekunle A Adeyomoye; Gbolahan O Awosanya; Mustapha A Danesi
Journal:  BMC Neurol       Date:  2008-07-12       Impact factor: 2.474

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.